MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals is developing a molecular synthetic THC (cannabinoid) drug to treat anxiety and cognitive decline typically associated with dementia. The company was formerly known as MIRA1A Therapeutics. (Incorporated in Florida) We are an early pre-clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic THC analog under investigation for the […]
July 18, 2023 Read More